Cart
sales@molnova.com
CAY10594
CAS No. 1130067-34-3
CAY10594( —— )
Catalog No. M20630 CAS No. 1130067-34-3
CAY10594 is a potent phospholipase D2(PLD2) inhibitor. CAY10594 ameliorates acetaminophen-induced acute liver injury by regulating the phosphorylated-GSK-3β/JNK axis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 169 | In Stock |
|
| 5MG | 155 | In Stock |
|
| 10MG | 264 | In Stock |
|
| 25MG | 472 | In Stock |
|
| 50MG | 672 | In Stock |
|
| 100MG | 918 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCAY10594
-
NoteResearch use only, not for human use.
-
Brief DescriptionCAY10594 is a potent phospholipase D2(PLD2) inhibitor. CAY10594 ameliorates acetaminophen-induced acute liver injury by regulating the phosphorylated-GSK-3β/JNK axis.
-
DescriptionCAY10594 is a potent phospholipase D2(PLD2) inhibitor. CAY10594 ameliorates acetaminophen-induced acute liver injury by regulating the phosphorylated-GSK-3β/JNK axis.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetPhospholipase
-
RecptorPLD2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1130067-34-3
-
Formula Weight428.5
-
Molecular FormulaC26H28N4O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:20mg/ml(46.7mM)
-
SMILESO=C(NCCN1CCC2(CC1)N(CNC2=O)c1ccccc1)c1ccc2ccccc2c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Lee SK Bae GH Kim YSet al.A phospholipase D2 inhibitor CAY10594 ameliorates acetaminophen-induced acute liver injury by regulating the phosphorylated-GSK-3β/JNK axis[J].Sci Rep. 2019 May 10;9(1):7242.
molnova catalog
related products
-
Darapladib
A potent Lp-PLA2 inhibitor with IC50 of 0.25 nM.
-
Abbolactone
Spironolactone is an Aldosterone Antagonist. The mechanism of action of spironolactone is as an Aldosterone Antagonist.
-
Varespladib
Varespladib (LY315920) is a potent and selective human non-pancreatic secretory phospholipase A2 (hnsPLA) inhibitor with IC50 of 7 nM. Phase 3.
